Drug Utilization Study in Congestive Heart Failure at a Tertiary Care Hospital

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2015, Vol 3, Issue 2

Abstract

The incidence and prevalence of Congestive heart failure (CHF) is increasing. Several large clinical trials have found that pharmacological therapy results in decrease in mortality and morbidity. Despite the advances in drug therapy the morbidity and mortality of heart failure continues to remain high. Education of healthcare professionals on evidence based therapy plays an important role in successful heart failure programme. For a developing country like India, 70% of the population resides in rural areas, a national drug policy is needed for rational drug use. To achieve this, pattern of usage and monitoring drug use profile over a period of time is important. There are very few studies available pertaining to drug utilization in heart failure. Hence the present study. The study was conducted in a tertiary care hospital in South India May 2011 to August 2012. Detailed history, chief complaints, physical signs & symptoms and investigations were recorded. During this period 100 prescriptions were collected. The data was analyzed using SPPS software. Almost all the patients received Diuretics either by oral or parenteral route. Majority of the patients were treated with ACE inhibitors or ARBs. Initial therapy was with diuretics in most of the cases and ACE inhibitors in few, further modified in some cases based on the response and later on β blockers and other drugs were added. A wide range of drugs were used in our study, the frequently used once were Diuretics, ACE inhibitors, angiotensin receptor blockers, Bronchodilators and Hypolipidemic agents. It was observed that daily defined dose (DDD) value was highest for Furosemide (1.130) and then was with ramipril (0.791), the least DDD was with Metoprolol (0.015). The use of Pharmacoepidemiological data can aid the design, delivery & evaluation of interventions to improve the use of drugs in CHF patients & health outcomes of the patients. Keywords: Congestive heart failure, Pharmacoepidemiology, Drug utilization, Furosemide.

Authors and Affiliations

Prasanna Kumar B. Jewargi, Ravi D. Mala

Keywords

Related Articles

Use of Checklist as a Tool for Prevention of Postpartum Adverse Events

Serious maternal complications like atonic postpartum haemorrhage, inversion of uterus, amniotic fluid embolism and cardiac failure are known to occur in immediate postpartum period. Use of checklist by gynaecology resid...

Prevalence of Cancer in a Tertiary Health Facility in South-South Nigeria

Abstract: Cancer remains a major public health problem with significant morbidity and mortality worldwide including Nigeria. This study assessed prevalence of cancer among patients managed at the Hematology/Oncology clin...

Bacteriological profile and their Antibiotic Sensitivity Pattern in Diabetic Foot Infections in a Tertiary Care Hospital

Abstract: Diabetes mellitus (DM) is a metabolic disorder of endocrine system which is a major health problem with rising prevalence worldwide and is associated with several complications. In India it is estimated to hav...

A Study of Group A Streptococcal Pharyngitis among School Children (3–15‑Year) of Urban Community

Abstract: Group A Beta Haemolytic Streptococcal (GABHS) is the most important gram positive cocci that is very frequently isolated pathogen in pharyngitis and causing pyogenic infections among school going children and w...

Bilateral Congenital Eyelid Coloboma and its Complications in a 2-year-old Child

Congenital eyelid coloboma is a partial or total absence of eyelid structures. It is present at birth and may cause damage to the cornea. This case report highlights the ocular complication of a bilateral coloboma in a 2...

Download PDF file
  • EP ID EP373363
  • DOI -
  • Views 46
  • Downloads 0

How To Cite

Prasanna Kumar B. Jewargi, Ravi D. Mala (2015). Drug Utilization Study in Congestive Heart Failure at a Tertiary Care Hospital. Scholars Journal of Applied Medical Sciences, 3(2), 857-862. https://europub.co.uk/articles/-A-373363